Department of Endocrinology, National Health Commission Key Laboratory of Endocrinology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
Chin Med J (Engl). 2019 Jan 20;132(2):145-153. doi: 10.1097/CM9.0000000000000013.
Osteogenesis imperfecta (OI), a heritable bone fragility disorder, is mainly caused by mutations in COL1A1 gene encoding α1 chain of type I collagen. This study aimed to investigate the COL1A1 mutation spectrum and quantitatively assess the genotype-phenotype relationship in a large cohort of Chinese patients with OI.
A total of 161 patients who were diagnosed as OI in Department of Endocrinology of Peking Union Medical College Hospital from January 2010 to December 2017 were included in the study. The COL1A1 mutation spectrum was identified by next generation sequencing and confirmed by Sanger sequencing. A new clinical scoring system was developed to quantitatively assess the clinical severity of OI and the genotype-phenotype relationship was analyzed. The independent sample t-test, analysis of variance, Mann-Whitney U-test, Chi-squared test, Pearson correlation, and multiple linear regression were applied for statistical analyses.
Among 161 patients with OI, 32.9% missense mutations, 16.8% non-sense mutations, 24.2% splice-site mutations, 24.8% frameshift mutations, and 1.2% whole-gene deletions were identified, of which 38 variations were novel. These mutations led to 53 patients carrying qualitative defects and 67 patients carrying quantitative defects in type I collagen. Compared to patients with quantitative mutations, patients with qualitative mutations had lower alkaline phosphatase level (296 [132, 346] U/L vs. 218 [136, 284] U/L, P = 0.009) and higher clinical score (12.2 ± 5.3 vs. 7.4 ± 2.4, P < 0.001), denoting more severe phenotypes including shorter stature, lower bone mineral density, higher fracture frequency, more bone deformity, vertebral compressive fractures, limited movement, and dentinogenesis imperfecta (DI). Patients would not present with DI if the glycine substitutions happened before the 79th amino acid in triple helix of α1 chains.
This presented distinctive COL1A1 mutation spectrum in a large cohort of Chinese patients with OI. This new quantitative analysis of genotype-phenotype correlation would be helpful to predict the prognosis of OI and genetic counseling.
成骨不全症(OI)是一种遗传性骨骼脆弱疾病,主要由Ⅰ型胶原α1 链编码基因 COL1A1 突变引起。本研究旨在调查中国 OI 患者大样本 COL1A1 突变谱,并定量评估基因型-表型关系。
纳入 2010 年 1 月至 2017 年 12 月北京协和医院内分泌科诊断为 OI 的 161 例患者,采用下一代测序技术鉴定 COL1A1 突变谱,并经 Sanger 测序验证。建立新的临床评分系统,对 OI 严重程度进行定量评估,并分析基因型-表型关系。应用独立样本 t 检验、方差分析、Mann-Whitney U 检验、卡方检验、Pearson 相关分析和多元线性回归进行统计学分析。
161 例 OI 患者中,32.9%为错义突变,16.8%为无义突变,24.2%为剪接位点突变,24.8%为移码突变,1.2%为全基因缺失,其中 38 种变异为新发现。这些突变导致 53 例患者 I 型胶原存在定性缺陷,67 例患者存在定量缺陷。与定量突变患者相比,定性突变患者碱性磷酸酶水平更低(296[132,346]U/L 比 218[136,284]U/L,P=0.009),临床评分更高(12.2±5.3 比 7.4±2.4,P<0.001),表型更严重,包括身材矮小、骨密度低、骨折频率高、骨骼畸形、椎体压缩性骨折、活动受限和牙本质生成不全(DI)。如果甘氨酸取代发生在α1 链三螺旋的第 79 个氨基酸之前,则不会出现 DI。
本研究呈现了中国 OI 患者大样本 COL1A1 突变谱的独特特征。这种新的基因型-表型相关性的定量分析有助于预测 OI 的预后和遗传咨询。